<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="144757">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01216189</url>
  </required_header>
  <id_info>
    <org_study_id>2008/247-31/3</org_study_id>
    <nct_id>NCT01216189</nct_id>
  </id_info>
  <brief_title>Sexual Function and Wellbeing in Females Diagnosed With Rectal Cancer</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Swedish Cancer Society</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Preoperative radiotherapy and pelvic surgery is recommended to many patients with rectal
      cancer.For women there are theoretical reasons to believe that the treatment may affect
      hormone levels, sexual function and wellbeing. To address these questions a longitudinal
      observational study was initiated where patients, before preoperative radiotherapy and one
      year after surgery, take blood tests and answer two questionnaires.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <secondary_outcome>
    <measure>Hormone levels</measure>
    <time_frame>2 year</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Rectal Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Females with rectal cancer stadium I-III, planned for abdominal surgery, with or without
        preoperative radiotherapy.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Females diagnosed with rectal cancer stadium I-III, planned surgery with or without
             preoperative radiotherapy.

        Exclusion Criteria:

          -  Rectal cancer stadium IV

          -  Previous radiotherapy to the pelvic region
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ersta Hospital</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gastrocentrum Kirurgi, Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <lastchanged_date>February 25, 2016</lastchanged_date>
  <firstreceived_date>October 4, 2010</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Anna Martling</investigator_full_name>
    <investigator_title>Associate Professor, Senior Consultant Surgeon</investigator_title>
  </responsible_party>
  <keyword>Rectal cancer</keyword>
  <keyword>Preoperative radiotherapy</keyword>
  <keyword>Pelvic surgery</keyword>
  <keyword>Sexual function</keyword>
  <keyword>Wellbeing</keyword>
  <keyword>Hormone levels</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
